OPTION: LAAO Matches Up to DOACs After Ablation, but …
1 day ago · Left atrial appendage occlusion (LAAO) appears to be a viable alternative to oral anticoagulation for stroke prevention in select patients undergoing catheter ablation for atrial fibrillation (AF), the OPTION trial shows. LAAO—performed with the Watchman FLX device (Boston Scientific) at the same ...
5-Year Results From the AMPLATZER Amulet Left Atrial Appendage …
2 days ago · Hildick-Smith D., Landmesser U., Camm A.J., et al. "Left atrial appendage occlusion with the Amplatzer Amulet device: full results of the prospective global observational study". Eur Heart J . 2020 ;41:2894-2901.
Abbott reports positive Amplatzer Amulet data
12 hours ago · The Amplatzer Amulet LAA occlusion device. [Image courtesy of Abbott] Abbott (NYSE:ABT) announced new data supporting its Amplatzer Amulet left atrial appendage (LAA) occluder system. The company ...
Left Atrial Appendage Occlusion Tied to Lower Ischemic Stroke …
5 days ago · Compared with continued oral anticoagulation therapy alone, left atrial appendage occlusion is linked to a lower risk for ischemic stroke in patients with nonvalvular atrial fibrillation (AF) plus a prior thromboembolic event, according to study results published in JAMA Neurology.. Researchers conducted a cohort study to compare percutaneous left atrial appendage occlusion with continued oral ...
Left atrial appendage closure safe, effective first-line ... - Healio
3 days ago · CHICAGO — In the OPTION trial, left atrial appendage closure resulted in similar thromboembolic protection but superior bleeding outcomes compared with oral anticoagulation among patients who ...
Boston Scientific WATCHMAN FLX™ Left Atrial Appendage …
4 days ago · The trial met the primary safety endpoint of non-procedural major bleeding or clinically relevant non-major bleeding at 36 months, with the WATCHMAN FLX device demonstrating superiority to OAC (8.5% vs.18.1%; P<0.0001).
Amulet IDE: Amulet Occluder vs. Watchman Device at Five-Year …
Nov 13, 2024 · Among patients at high risk of stroke or systemic embolism, the AMPLATZER Amulet left atrial appendage (LAA) occluder was as safe and effective as the Watchman 2.5 device at five-year follow-up, according to results from the Amulet IDE trial, presented at AHA 2024 and simultaneously published in JACC.Additionally, patients with the Amulet occluder were less likely to suffer severe strokes or ...
Left Atrial Appendage Closure after Ablation for Atrial Fibrillation
4 days ago · A total of 803 patients were assigned to undergo left atrial appendage closure, and 797 to receive anticoagulant therapy. The mean (±SD) age of the patients was 69.6±7.7 years, 34.1% of the ...
Left Atrial Appendage Occlusion vs Standard of Care After …
Left atrial appendage occlusion (LAAO) is a mechanical stroke prevention strategy that may provide additional protection in patients with thromboembolic events under OAT. Objective To compare percutaneous LAAO with continuing OAT alone regarding stroke prevention in patients with AF who had a thromboembolic event despite taking OAT.
Left Atrial Appendage Occlusion in Patients Without Atrial …
Sep 11, 2024 · Stroke Prevention With Prophylactic Left Atrial Appendage Occlusion in Cardiac Surgery Patients Without Atrial Fibrillation: A Meta-Analysis of Randomized and Propensity-Score Studies